Dr. Rowan Miller is a Consultant Medical Oncologist specialising in gynae-oncology and early phase clinical trials at University College London and St Bartholomew’s Hospitals. Her research interests include novel therapies for gynaecological cancer and utilising genomics and biomarkers to guide therapy in patients, particularly in early-phase clinical trials.

Dr. Miller completed her undergraduate training at the University of Oxford and clinical training at Guy’s and St Thomas’ Hospitals, London. She trained in Medical Oncology at University College London and was subsequently awarded a Cancer Research UK Fellowship and attained a PhD from the Institute of Cancer Research. Following her PhD, Dr. Miller completed a fellowship at Dana Farber Cancer Institute, Harvard University.

Dr. Miller is involved in a number of clinical trials and core ESMO Translational Research and Precision Medicine Working Group and led their consensus recommendation paper on HRD testing in ovarian cancer.